by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
In five years, Novo Nordisk has created a multiple blockbuster drug in diabetes treatment Ozempic, which has been center stage in transforming the Danish pharmaceutical firm’s sales.
With an approval falling in December 2017, sales of the drug amounted to literally nothing that year. The year after, sales ”barely” reached DKK 1.8bn (USD 273.4m). In 2021, sales were catapulted to nothing less than DKK 33.7bn (USD 5.1bn). With a threshold of USD 1bn, Ozempic is thus a blockbuster five times over.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
WS Audiology brings in head of EMEA region from Coloplast
The hearing aid manufacturer has appointed Coloplast’s now outgoing president for emerging markets as president for the EMEA region.
Dupixent could dominate pediatric eczema market for up to a decade, analysis finds
Sanofi and Regeneron will be able to call themselves market leaders within atopic eczema treatment for children aged 6 months to 5 for years to come, according to Globaldata.
FDA advisors support approval for Ferring's intestinal infection medicine
All signs indicate that Ferring Pharmaceuticals is on the cusp of being market authorized for its biologic candidate against C. difficile infection.
Pharmacosmos expects massive growth in four years
The company’s new chief executive has ambitions of reaching a DKK 2.5bn (USD 325m) revenue within the time frame.
The Lundbeck Foundation, ATP, LEGO asset manager join forces on secretive project
Three of Denmark’s biggest funds have come together for a yet unknown project, which includes the establishment of three new firms.
Senior CMC & Device Project Manager 
Product specialist in Cardio Rhythm Management, Zealand 
Senior Manager, System Change & Release Management 
Sales Manager Denmark 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Scientist Radiochemistry 
Vice President, Medical Affairs 
Calibration Technician 
Lab Manager 
Pharmacovigilance & Regulatory Assistant with an interest in non-fiction 
Product specialist 
Manager of QA, BHS Logistics 
Clinical Project Lead 
Senior/lead consultant at Emendo Engineering